Registered entities
Amphista Therapeutics Limited
Reg. No. 11119959United Kingdom
Innovation
40 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 365 times.
| Year | Filings |
|---|---|
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 7 |
| 2023 | 15 |
| 2024 | 8 |
| 2025 | 13 |
| 2026 | 2 |
Social engagement
Social engagement: 13.2K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include Advent Life Sciences, Gilde Healthcare, Forbion.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 33% |
| Private equity | 2 | 17% |
| Other / undisclosed | 6 | 50% |
Recent activity
15 Jun 2026
Event
Decouvert and Development Europe 2026 conference
11 Jun 2026
Event
Cambridge Wide Open Week
4 Jun 2026
Event
EHA 2026 Congress